Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Real-world association between systemic corticosteroid exposure and complications in US patients with severe asthma

Fig. 1

Study design. *First pharmacy/medical claim date for SCS ≥ 5 mg/day following 6 months of continuous (≥ 5 mg/day for 6 months without any gap > 14 days between claims) SCS use (SCS use cohort) or date of initiation of any non-SCS asthma controller/rescue medication (non/burst-SCS use cohort). SCS, systemic corticosteroid

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us